Drug giant Pfizer Inc. says its second-quarter profit plunged 19 percent, as the strong dollar pulled down revenue and higher taxes and costs for its pending purchase of rival Wyeth hurt the bottom line.
By THE ASSOCIATED PRESS, NY Times: Business
Wed, 07/22/2009 - 4:27am
Drug giant Pfizer Inc. says its second-quarter profit plunged 19 percent, as the strong dollar pulled down revenue and higher taxes and costs for its pending purchase of rival Wyeth hurt the bottom line.